Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate, GB001, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback